In fact, the individuals with familial renal glucosuria, a genetic loss of SGLT2 function, do not generally suffer from hypoglycemia, an observation which supports the safety of the use of SGLT2 inhibitors [186]. This evidence concerns the gene SLC5A2 and Hypoglycemia.